Viridian Therapeutics, Inc.\DE (VRDN)
Since Nov 14, 2014, Viridian Therapeutics, Inc.\DE (VRDN) has reported earnings 43 times. On average the shares move ±7.17% post-earnings, with a positive reaction 48.8% of the time. Its largest post-earnings gain was +49.36% (Aug 15, 2022) and its largest decline was -17.2% (Aug 07, 2019). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings reactions
How VRDN moved on each past earnings report.
Earnings Impact
Total Earnings
43
Avg Abs. Movement
±7.17%
Positive %
48.8%
Negative %
51.2%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 05, 2026 | ☀ PRE | +33.89% | open_in_new |
| Feb 26, 2026 | ☀ PRE | +1.9% | open_in_new |
| Nov 05, 2025 | ☀ PRE | +8.29% | open_in_new |
| Aug 06, 2025 | ☀ PRE | -1.38% | open_in_new |
Earnings Count
43
Total earnings in dataset
Avg Abs. Movement
±7.17%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 8-K | 20260629 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260626 | open_in_new SEC.gov |
| 8-K | 20260603 | open_in_new SEC.gov |
| 8-K | 20260528 | open_in_new SEC.gov |
Frequently asked about VRDN earnings
When does Viridian Therapeutics, Inc.\DE report earnings next? expand_more
Viridian Therapeutics, Inc.\DE (VRDN)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does VRDN stock move after earnings? expand_more
Over 43 reports, VRDN has moved an average of ±7.17% the session after earnings, closing higher 48.8% of the time.
What was VRDN's biggest post-earnings move? expand_more
VRDN's largest post-earnings gain on record was +49.36% on Aug 15, 2022, and its largest decline was -17.2% on Aug 07, 2019.
Where can I find Viridian Therapeutics, Inc.\DE's SEC filings? expand_more
All of Viridian Therapeutics, Inc.\DE's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07